GENERIC NAME OF THE MEDICINAL PRODUCT:
B) Sodium Valproate & Valproic acid Controlled Release Tablets 200mg+87mg
C) Sodium Valproate & Valproic acid Controlled Release Tablets 333mg+145mg
D) Sodium Valproate & Valproic acid Controlled Release Tablets 499mg+217mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
Each film coated Controlled Release tablet contains:
Sodium Valproate IP……………………135mg
Valproic acid IP…………………………….58mg
(Both together corresponds to sodium valproate IP 150mg)
Excipients………………………………………q.s.
Colour: Erythrosine
B) Sodium Valproate & Valproic acid Controlled Release Tablets 200mg+87mg
Each film coated Controlled Release tablet contains:
Sodium Valproate IP…………………….200mg
Valproic acid IP……………………………….87mg
(Both together corresponds to sodium valproate IP 250mg)
Excipients……………………………………..q.s.
Colour: Ponceau 4 R
C) Sodium Valproate & Valproic acid Controlled Release Tablets 333mg+145mg
Each film coated Controlled Release tablet contains:
Sodium Valproate IP…………………333mg
Valproic acid IP…………………………145mg
(Both together corresponds to sodium valproate IP 500mg)
Excipients…………………………………..q.s.
Colour: Quinoline yellow SS
D) Sodium Valproate & Valproic acid Controlled Release Tablets 499mg+217mg
Each film coated Controlled Release tablet contains:
Sodium Valproate IP…………………..499mg
Valproic acid IP……………………………217mg
(Both together corresponds to sodium valproate IP 750mg)
Excipients………………………………………q.s.
Colour: Lake brilliant blue
THERAPEUTIC INDICATIONS:
CAUTION & WARNING
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH.
WARNING : NOT TO BE SOLD BY RETAIL WITHOUT THE PRESCRIPTION OF A REGISTERED MEDICAL PRACTITIONER.
STORAGE & DOSAGE:
Protect from Light.
Dosage: As directed by the Physician.
Sodium Valproate & Valproic acid Controlled Release Tablets 200mg+87mg Technical Specification:
| Product Name: | Sodium Valproate & Valproic acid Controlled Release Tablets |
| Brand Name: | Generic |
| Strength: | 135mg+58mg, 200mg+87mg, 333mg+145mg, 499mg+217mg |
| Dosage Form: | Tablets (Uncoated) |
| Route of Administration: | Via Oral Route |
| Packing: | 10s, 30s, 100s, 500s |
| Pack Insert/Leaflet: | PIL (Patient Information Leaflet) |
| Documents: | COA, MOA, Stability Studies, GMP |
| Therapeutic use: | Antiepileptic, Anticonvulsant |
| Indication: | Sodium Valproate + Valproic Acid is used in the treatment of epilepsy. |
| Storage: | Store below 30 °C. Protect from Light. |
GENERIC NAME OF THE MEDICINAL PRODUCT:
A) Sodium Valproate & Valproic acid Controlled Release Tablets 135mg+58mg
B) Sodium Valproate & Valproic acid Controlled Release Tablets 200mg+87mg
C) Sodium Valproate & Valproic acid Controlled Release Tablets 333mg+145mg
D) Sodium Valproate & Valproic acid Controlled Release Tablets 499mg+217mg
QUALITATIVE AND QUANTITATIVE COMPOSITION:
A) Sodium Valproate & Valproic acid Controlled Release Tablets 135mg+58mg
Each film coated Controlled Release tablet contains:
Sodium Valproate IP……………………135mg
Valproic acid IP…………………………….58mg
(Both together corresponds to sodium valproate IP 150mg)
Excipients………………………………………q.s.
Colour: Erythrosine
B) Sodium Valproate & Valproic acid Controlled Release Tablets 200mg+87mg
Each film coated Controlled Release tablet contains:
Sodium Valproate IP…………………….200mg
Valproic acid IP……………………………….87mg
(Both together corresponds to sodium valproate IP 250mg)
Excipients……………………………………..q.s.
Colour: Ponceau 4 R
C) Sodium Valproate & Valproic acid Controlled Release Tablets 333mg+145mg
Each film coated Controlled Release tablet contains:
Sodium Valproate IP…………………333mg
Valproic acid IP…………………………145mg
(Both together corresponds to sodium valproate IP 500mg)
Excipients…………………………………..q.s.
Colour: Quinoline yellow SS
D) Sodium Valproate & Valproic acid Controlled Release Tablets 499mg+217mg
Each film coated Controlled Release tablet contains:
Sodium Valproate IP…………………..499mg
Valproic acid IP……………………………217mg
(Both together corresponds to sodium valproate IP 750mg)
Excipients………………………………………q.s.
Colour: Lake brilliant blue
THERAPEUTIC INDICATIONS:
Sodium Valproate + Valproic Acid is used in the treatment of epilepsy.
CAUTION & WARNING:
CAUTION: Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH.
WARNING: NOT TO BE SOLD BY RETAIL WITHOUT THE PRESCRIPTION OF A REGISTERED MEDICAL PRACTITIONER.
STORAGE & DOSAGE:
Storage: Store below 30 °C.
Protect from Light.
Dosage: As directed by the Physician.
Introduction to Sodium Valproate & Valproic Acid Controlled Release Tablets 200mg+87mg
Sodium Valproate & Valproic acid Controlled Release Tablets 200mg+87mg are a combination of two powerful antiepileptic medications used to manage epilepsy, bipolar disorder, and migraine prevention. The controlled-release formulation ensures gradual and sustained release of the drug, improving therapeutic efficiency while reducing side effects.
Sodium Valproate and Valproic Acid work by increasing gamma-aminobutyric acid (GABA) levels in the brain, a neurotransmitter that stabilizes neuronal activity, preventing seizures and mood swings.
Globally, the demand for these medications has surged due to:
-
Rising prevalence of neurological disorders
-
Increased awareness about mental health treatments
-
Adoption of controlled-release formulations for improved patient compliance
Taj Pharma, a trusted manufacturer and exporter based in Vapi, Gujarat, India, provides high-quality, WHO-GMP-certified Sodium Valproate & Valproic acid Controlled Release Tablets to meet this growing global demand.
2. In-Depth Details for Importers, Exporters, and Buyers
Regulatory Documentation Provided
Taj Pharma offers complete regulatory support to international buyers, including:
-
Certificate of Analysis (COA)
-
WHO-GMP Certification
-
EU-GMP compliance
-
Certificate of Pharmaceutical Product (COPP)
-
CTD/ACTD Dossiers for registration
-
Free Sale Certificate (FSC)
-
Stability data and batch records according to ICH guidelines
These documents ensure seamless import and compliance with global regulatory authorities.
Custom Packaging & Labeling
The company provides flexible packaging options tailored to global markets:
-
Alu-Alu blisters for tablets
-
HDPE bottles for bulk supply
-
Private labeling with distributor branding
-
Compliance with country-specific regulatory labeling requirements
This allows buyers and distributors to receive market-ready products in accordance with local regulations.
Shelf-Life, Storage, and Dosage Form
-
Dosage Form: Controlled-Release Tablet
-
Strength: 200mg Sodium Valproate + 87mg Valproic Acid
-
Shelf-life: 24–36 months
-
Storage: Store below 25°C in a dry, cool place, away from direct sunlight
Export Certifications
Taj Pharma ensures international regulatory compliance by holding:
-
WHO-GMP Certification
-
EU-GMP Certification
-
ISO 9001:2015
-
COPP for multiple countries
-
CTD/ACTD dossiers
These certifications guarantee high-quality antiepileptic tablets that meet global standards.
Target Countries & Export Markets
Taj Pharma exports Sodium Valproate & Valproic Acid Controlled Release Tablets to more than 50 countries, including:
-
Asia: Bangladesh, Nepal, Sri Lanka, Philippines, Vietnam
-
Africa: Nigeria, Kenya, Ghana, Tanzania, Uganda
-
Middle East: UAE, Oman, Iraq, Yemen
-
CIS Countries: Kazakhstan, Uzbekistan, Georgia, Ukraine
-
Latin America: Peru, Ecuador, Bolivia
3. Why Taj Pharma is the Most Trusted Manufacturer/Supplier/Exporter
A. State-of-the-Art Manufacturing
Taj Pharma’s Vapi facility is equipped with:
-
Advanced cleanroom production environments
-
Automated tablet compression machines
-
Sophisticated quality control laboratories
-
In-process and finished product testing
Each batch of Sodium Valproate & Valproic acid Controlled Release Tablets 200mg+87mg undergoes stringent quality checks to ensure purity, potency, and safety.
B. Affordable Pricing & Quality Assurance
Taj Pharma maintains competitive pricing by:
-
In-house API sourcing
-
Optimized manufacturing processes
-
Internationally recognized quality control
This makes high-quality antiepileptic tablets accessible to global buyers without compromising on quality.
C. Global Presence & Supply Chain Support
Taj Pharma provides:
-
Timely door-to-port shipping
-
Assistance with import registration
-
Bulk supply for hospitals, distributors, and institutional tenders
-
Real-time inventory and shipment tracking
This ensures consistent supply and global availability.
D. Top 20 Countries Exporting
Nigeria, Kenya, Ghana, Iraq, UAE, Saudi Arabia, Bangladesh, Sri Lanka, Vietnam, Ukraine, Uzbekistan, Colombia, Peru, Ecuador, Philippines, Tanzania, Myanmar, Cambodia, Jordan, Zambia
4. Technical Product Specification Table
| Product Name | Sodium Valproate & Valproic Acid Controlled Release Tablets |
|---|---|
| Brand Name | Taj Pharma |
| Active Ingredients | Sodium Valproate 200mg, Valproic Acid 87mg |
| Dosage Form | Controlled-Release Tablet |
| Indication | Epilepsy, Bipolar Disorder, Migraine Prevention |
| Packing | 10×10 / 10×14 / 10×28 Alu-Alu Blisters |
| Manufacturer | Taj Pharmaceuticals Ltd., Vapi, Gujarat, India |
| Storage | Store below 25°C, dry place, avoid sunlight |
| Shelf Life | 24–36 months |
| Certifications | WHO-GMP, ISO, COPP, EU-GMP |
| Dossier Type | CTD / ACTD available |
5. Call to Action
For reliable WHO-GMP-certified Sodium Valproate & Valproic acid Controlled Release Tablets 200mg+87mg manufacturer in India, Taj Pharma is your ideal partner.
Contact Taj Pharma for:
-
Competitive pricing and bulk supply
-
Private labeling and contract manufacturing
-
Complete regulatory dossier support
-
PCD Pharma Franchise opportunities
📞 Contact:
Taj Pharmaceuticals Ltd., Vapi, Gujarat, India
🌐 www.tajpharma.in
✉️ Email: info@tajpharma.com
6. Top 20 FAQs
1. What is Sodium Valproate & Valproic Acid used for?
To treat epilepsy, bipolar disorder, and prevent migraines.
2. Who manufactures these tablets in India?
Taj Pharma is a leading manufacturer and exporter.
3. Are these tablets WHO-GMP certified?
Yes, Taj Pharma’s facility is WHO-GMP certified.
4. Can buyers request private labeling?
Yes, private labeling and custom packaging are available.
5. What is the shelf life?
24–36 months under proper storage conditions.
6. Are there side effects?
Common effects include weight gain, sleepiness, tremors, and dizziness.
7. How do these tablets work?
They increase GABA levels to stabilize neuronal activity.
8. Are they suitable for long-term use?
Yes, under strict medical supervision.
9. Can they prevent migraines?
Yes, these tablets reduce migraine frequency and severity.
10. What are the packing options?
Alu-Alu blisters and HDPE bottles for bulk supply.
11. Are these tablets exported globally?
Yes, Taj Pharma exports to over 50 countries.
12. Are CTD dossiers available for registration abroad?
Yes, CTD / ACTD dossiers are provided.
13. Do these tablets require prescription?
Yes, they are prescription-only medications.
14. Can they cause liver injury?
Rarely; liver function monitoring is recommended.
15. How should they be stored?
Store below 25°C in a dry place, away from sunlight.
16. Can distributors order in bulk?
Yes, Taj Pharma supplies low MOQ and bulk orders.
17. Are they safe during pregnancy?
Only under strict medical supervision due to fetal risk.
18. Do these tablets interact with other medications?
Yes, consult a healthcare professional for potential interactions.
19. Does Taj Pharma provide supply chain support?
Yes, including tracking and import registration assistance.
20. How to contact Taj Pharma for orders?
Visit www.tajpharma.in or email info@tajpharma.com.
Taj Pharma is the leading manufacturer, supplier, and exporter of Sodium Valproate & Valproic Acid Controlled Release Tablets 200mg+87mg in India, offering WHO-GMP-certified, high-quality, and globally compliant antiepileptic tablets.
For importers, distributors, and PCD franchise partners, Taj Pharma provides quality assurance, competitive pricing, regulatory support, and reliable supply, making it the preferred choice for neurological medications worldwide.
Sodium Valproate & Valproic Acid Controlled Release Tablets 200mg+87mg Manufacturer in India | Taj Pharma – Your Trusted Global Partner.






